Improved vectors for ocular gene therapy

Researchers studying wearable device to detect COVID-19 upon infection
22 February 2021
Pfizer to begin clinical trial of COVID-19 vaccine in pregnant women
22 February 2021

Improved vectors for ocular gene therapy

Strategies based on the use of gene therapy to mitigate the effects of mutations that cause blindness are undergoing rapid development. Novel gene vectors now achieve widespread gene delivery and reduce the risks associated with these approaches.

Comments are closed.